UCBJF UCB S.A.
- 178.500
- 0.0000.00%
UCB S.A. News
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage
Barclays Maintains UCB S.A.(UCBJF.US) With Buy Rating, Cuts Target Price to $193.14
Barclays Maintains UCB S.A.(UCBJF.US) With Buy Rating, Raises Target Price to $193.4
Citi Maintains UCB S.A.(UCBJF.US) With Buy Rating, Raises Target Price to $196.72
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
Barclays Maintains UCB S.A.(UCBJF.US) With Buy Rating, Cuts Target Price to $194.76
Belgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management Companies
J.P. Morgan Upgrades UCB S.A.(UCBJF.US) to Buy Rating, Raises Target Price to $222.54
Citi Maintains UCB S.A.(UCBJF.US) With Buy Rating, Raises Target Price to $198.36
Citi Maintains UCB S.A.(UCBJF.US) With Buy Rating, Raises Target Price to $177.66
Barclays Maintains UCB S.A.(UCBJF.US) With Buy Rating, Raises Target Price to $191.36
European Exporters With Stretched Valuations - JPM
Barclays Maintains UCB S.A.(UCBJF.US) With Buy Rating, Cuts Target Price to $191.07
Citi Maintains UCB S.A.(UCBJF.US) With Buy Rating, Cuts Target Price to $175.78
UBS Maintains UCB S.A.(UCBJF.US) With Buy Rating, Raises Target Price to $194.9
Jefferies Maintains UCB S.A.(UCBJF.US) With Buy Rating, Raises Target Price to $200.13
Barclays Maintains UCB S.A.(UCBJF.US) With Buy Rating, Raises Target Price to $189.31
Kepler Capital Maintains UCB S.A.(UCBJF.US) With Hold Rating, Raises Target Price to $159.83
Oddo BHF Upgrades UCB S.A.(UCBJF.US) to Buy Rating, Raises Target Price to $182.66
UCB SA Reports 1H Results
Analysis
Price Target
No Data
